Bulgaria – Pharmaceutical products – Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health
Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry o
Opportunity description
Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health. The contractor agrees, after receiving a letter of consent from the Bulgarian Drug Agency (BDA) and a written request for delivery of the medicinal product specified below, to deliver the following medicinal product in the quantities prescribed by “UMHAT St. Ivan Rilski” EAD by means of a protocol – Appendix No. 1 (which is applicable), issued in accordance with Ordinance No. 10 / 17.11.2011, according to the CONTRACTOR'S offer. - International non-proprietary name: Ganaxolone, Ztalmy, BAlmac Pharma Services Limited, Oral suspension, 50mg/ml, 110ml, bottle, number of dosage forms per package- 1, quantity of packages -15; Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.